MMP3 and neoplasm: In vivo, MMP3-siRNA therapy alone did not significantly reduce tumor size; however, when combined with cisplatin, it resulted in a marked decrease in tumor growth, proliferation, and angiogenesis, reinforcing MMP3’s role in mediating chemoresistance.